- Home
- INBK vs CRVS Comparison
INBK vs CRVS Comparison
Compare INBK & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBK
- CRVS
- Stock Information
- Founded
- INBK 1999
- CRVS 2014
- Country
- INBK United States
- CRVS United States
- Employees
- INBK N/A
- CRVS N/A
- Industry
- INBK Major Banks
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- INBK Finance
- CRVS Health Care
- Exchange
- INBK Nasdaq
- CRVS Nasdaq
- Market Cap
- INBK 228.1M
- CRVS 206.5M
- IPO Year
- INBK N/A
- CRVS 2016
- Fundamental
- Price
- INBK $23.23
- CRVS $4.43
- Analyst Decision
- INBK Buy
- CRVS Strong Buy
- Analyst Count
- INBK 4
- CRVS 3
- Target Price
- INBK $34.50
- CRVS $16.33
- AVG Volume (30 Days)
- INBK 93.3K
- CRVS 1.4M
- Earning Date
- INBK 04-23-2025
- CRVS 05-08-2025
- Dividend Yield
- INBK 1.04%
- CRVS N/A
- EPS Growth
- INBK 27.37
- CRVS N/A
- EPS
- INBK 2.40
- CRVS N/A
- Revenue
- INBK $114,609,000.00
- CRVS N/A
- Revenue This Year
- INBK $3.03
- CRVS N/A
- Revenue Next Year
- INBK $16.38
- CRVS N/A
- P/E Ratio
- INBK $9.61
- CRVS N/A
- Revenue Growth
- INBK 20.13
- CRVS N/A
- 52 Week Low
- INBK $19.54
- CRVS $1.75
- 52 Week High
- INBK $43.26
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- INBK 49.58
- CRVS 68.59
- Support Level
- INBK $21.59
- CRVS $3.17
- Resistance Level
- INBK $22.56
- CRVS $3.71
- Average True Range (ATR)
- INBK 1.33
- CRVS 0.23
- MACD
- INBK 0.33
- CRVS 0.08
- Stochastic Oscillator
- INBK 50.62
- CRVS 95.47
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking/treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).